These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37792954)

  • 21. Serosurvey of Immunity to Monkeypox (Mpox) Virus Antigens in People Living with HIV in South Florida.
    Kupritz J; Pahwa S; Pallikkuth S
    Pathogens; 2023 Nov; 12(11):. PubMed ID: 38003819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of
    Chiem K; Nogales A; Lorenzo M; Morales Vasquez D; Xiang Y; Gupta YK; Blasco R; de la Torre JC; Martínez-Sobrido L
    Microbiol Spectr; 2023 Aug; 11(4):e0474522. PubMed ID: 37278625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological responses to smallpox A33 antigen and monkeypox A35 antigen in healthy people and people living with HIV-1 from Guangzhou, China.
    Dai J; Li F; Yang Y; Tang X; Li L; Yu H
    J Med Virol; 2023 May; 95(5):e28763. PubMed ID: 37212313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of smallpox vaccines against Mpox infections in humans.
    Christodoulidou MM; Mabbott NA
    Immunother Adv; 2023; 3(1):ltad020. PubMed ID: 37886620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation and comparison of immune responses induced by two Mpox mRNA vaccine candidates in mice.
    Yang X; Hu C; Yang X; Yang X; Hu X; Wang X; Liu C; Yuan Y; Du S; Wang PG; Lin J
    J Med Virol; 2023 Oct; 95(10):e29140. PubMed ID: 37800627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
    Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge.
    Zeng J; Li Y; Jiang L; Luo L; Wang Y; Wang H; Han X; Zhao J; Gu G; Fang M; Huang Q; Yan J
    Emerg Microbes Infect; 2023 Dec; 12(1):2204151. PubMed ID: 37070521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity.
    Zhang N; Cheng X; Zhu Y; Mo O; Yu H; Zhu L; Zhang J; Kuang L; Gao Y; Cao R; Liang X; Wang H; Li H; Li S; Zhong W; Li X; Li X; Hao P
    Sci China Life Sci; 2023 Oct; 66(10):2329-2341. PubMed ID: 37300753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge.
    Mucker EM; Golden JW; Hammerbeck CD; Kishimori JM; Royals M; Joselyn MD; Ballantyne J; Nalca A; Hooper JW
    J Virol; 2022 Feb; 96(3):e0150421. PubMed ID: 34851148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus.
    Li E; Guo X; Hong D; Gong Q; Xie W; Li T; Wang J; Chuai X; Chiu S
    Signal Transduct Target Ther; 2023 Sep; 8(1):350. PubMed ID: 37709783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara.
    Volz A; Langenmayer M; Jany S; Kalinke U; Sutter G
    J Virol; 2014 Sep; 88(18):10946-57. PubMed ID: 25008931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
    Priyamvada L; Carson WC; Ortega E; Navarra T; Tran S; Smith TG; Pukuta E; Muyamuna E; Kabamba J; Nguete BU; Likafi T; Kokola G; Lushima RS; Tamfum JM; Okitolonda EW; Kaba DK; Monroe BP; McCollum AM; Petersen BW; Satheshkumar PS; Townsend MB
    Vaccine; 2022 Nov; 40(50):7321-7327. PubMed ID: 36344361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.
    Clark KM; Johnson JB; Kock ND; Mizel SB; Parks GD
    Virology; 2011 Oct; 419(2):97-106. PubMed ID: 21885079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.
    Arndt WD; Cotsmire S; Trainor K; Harrington H; Hauns K; Kibler KV; Huynh TP; Jacobs BL
    J Virol; 2015 Oct; 89(20):10489-99. PubMed ID: 26246580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From?
    Tiecco G; Degli Antoni M; Storti S; Tomasoni LR; Castelli F; Quiros-Roldan E
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.
    Earl PL; Americo JL; Wyatt LS; Eller LA; Whitbeck JC; Cohen GH; Eisenberg RJ; Hartmann CJ; Jackson DL; Kulesh DA; Martinez MJ; Miller DM; Mucker EM; Shamblin JD; Zwiers SH; Huggins JW; Jahrling PB; Moss B
    Nature; 2004 Mar; 428(6979):182-5. PubMed ID: 15014500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.
    Stittelaar KJ; van Amerongen G; Kondova I; Kuiken T; van Lavieren RF; Pistoor FH; Niesters HG; van Doornum G; van der Zeijst BA; Mateo L; Chaplin PJ; Osterhaus AD
    J Virol; 2005 Jun; 79(12):7845-51. PubMed ID: 15919938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects.
    Sammartino JC; Cassaniti I; Ferrari A; Piralla A; Bergami F; Arena FA; Paolucci S; Rovida F; Lilleri D; Percivalle E; Baldanti F
    J Med Virol; 2023 May; 95(5):e28778. PubMed ID: 37212258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
    Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.